Condition
Posterior Cortical Atrophy (PCA)
Total Trials
5
Recruiting
0
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 1 (1)
Trial Status
Completed2
Enrolling By Invitation2
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT02740634Not ApplicableActive Not Recruiting
Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study
NCT07222605Not ApplicableEnrolling By Invitation
Research Study for Patients With Neurological Diseases Which Evaluates the Patient Experience of the MemorEM Device
NCT07049341Not ApplicableEnrolling By Invitation
Pilot Trial Evaluating Patient Experience With the MemorEM for Patients With Neurological Diseases
NCT02289118Completed
Tau Imaging in Young Onset Dementia
NCT01723553Phase 1Completed
Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD
Showing all 5 trials